Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302

NCT02317562 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

19

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor's decision

Conditions

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Interventions

DRUG: I10E

Sponsor

Laboratoire français de Fractionnement et de Biotechnologies